Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers

Masatoshi Maeki, Yuka Fujishima, Yusuke Sato, Takao Yasui, Noritada Kaji, Akihiko Ishida, Hirofumi Tani, Yoshinobu Baba, Hideyoshi Harashima, Manabu Tokeshi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Lipid nanoparticles (LNPs) or liposomes are the most widely used drug carriers for nanomedicines. The size of LNPs is one of the essential factors affecting drug delivery efficiency and therapeutic efficiency. Here, we demonstrated the effect of lipid concentration and mixing performance on the LNP size using microfluidic devices with the aim of understanding the LNP formation mechanism and controlling the LNP size precisely. We fabricated microfluidic devices with different depths, 11 μm and 31 μm, of their chaotic micromixer structures. According to the LNP formation behavior results, by using a low concentration of the lipid solution and the microfluidic device equipped with the 31 μm chaotic mixer structures, we were able to produce the smallest-sized LNPs yet with a narrow particle size distribution. We also evaluated the mixing rate of the microfluidic devices using a laser scanning confocal microscopy and we estimated the critical ethanol concentration for controlling the LNP size. The critical ethanol concentration range was estimated to be 60–80% ethanol. Ten nanometer-sized tuning of LNPs was achieved for the optimum residence time at the critical concentration using the microfluidic devices with chaotic mixer structures. The residence times at the critical concentration necessary to control the LNP size were 10, 15–25, and 50 ms time-scales for 30, 40, and 50 nm-sized LNPs, respectively. Finally, we proposed the LNP formation mechanism based on the determined LNP formation behavior and the critical ethanol concentration. The precise size-controlled LNPs produced by the microfluidic devices are expected to become carriers for next generation nanomedicines and they will lead to new and effective approaches for cancer treatment.

Original languageEnglish
Article numbere0187962
JournalPloS one
Volume12
Issue number11
DOIs
Publication statusPublished - Nov 2017
Externally publishedYes

Fingerprint

Lab-On-A-Chip Devices
nanoparticles
Microfluidics
Nanoparticles
Lipids
lipids
nanomedicine
Ethanol
ethanol
Nanomedicine
Medical nanotechnology
mixers

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Cite this

Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers. / Maeki, Masatoshi; Fujishima, Yuka; Sato, Yusuke; Yasui, Takao; Kaji, Noritada; Ishida, Akihiko; Tani, Hirofumi; Baba, Yoshinobu; Harashima, Hideyoshi; Tokeshi, Manabu.

In: PloS one, Vol. 12, No. 11, e0187962, 11.2017.

Research output: Contribution to journalArticle

Maeki, M, Fujishima, Y, Sato, Y, Yasui, T, Kaji, N, Ishida, A, Tani, H, Baba, Y, Harashima, H & Tokeshi, M 2017, 'Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers', PloS one, vol. 12, no. 11, e0187962. https://doi.org/10.1371/journal.pone.0187962
Maeki, Masatoshi ; Fujishima, Yuka ; Sato, Yusuke ; Yasui, Takao ; Kaji, Noritada ; Ishida, Akihiko ; Tani, Hirofumi ; Baba, Yoshinobu ; Harashima, Hideyoshi ; Tokeshi, Manabu. / Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers. In: PloS one. 2017 ; Vol. 12, No. 11.
@article{bc51fc60428846be8114e82164737699,
title = "Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers",
abstract = "Lipid nanoparticles (LNPs) or liposomes are the most widely used drug carriers for nanomedicines. The size of LNPs is one of the essential factors affecting drug delivery efficiency and therapeutic efficiency. Here, we demonstrated the effect of lipid concentration and mixing performance on the LNP size using microfluidic devices with the aim of understanding the LNP formation mechanism and controlling the LNP size precisely. We fabricated microfluidic devices with different depths, 11 μm and 31 μm, of their chaotic micromixer structures. According to the LNP formation behavior results, by using a low concentration of the lipid solution and the microfluidic device equipped with the 31 μm chaotic mixer structures, we were able to produce the smallest-sized LNPs yet with a narrow particle size distribution. We also evaluated the mixing rate of the microfluidic devices using a laser scanning confocal microscopy and we estimated the critical ethanol concentration for controlling the LNP size. The critical ethanol concentration range was estimated to be 60–80{\%} ethanol. Ten nanometer-sized tuning of LNPs was achieved for the optimum residence time at the critical concentration using the microfluidic devices with chaotic mixer structures. The residence times at the critical concentration necessary to control the LNP size were 10, 15–25, and 50 ms time-scales for 30, 40, and 50 nm-sized LNPs, respectively. Finally, we proposed the LNP formation mechanism based on the determined LNP formation behavior and the critical ethanol concentration. The precise size-controlled LNPs produced by the microfluidic devices are expected to become carriers for next generation nanomedicines and they will lead to new and effective approaches for cancer treatment.",
author = "Masatoshi Maeki and Yuka Fujishima and Yusuke Sato and Takao Yasui and Noritada Kaji and Akihiko Ishida and Hirofumi Tani and Yoshinobu Baba and Hideyoshi Harashima and Manabu Tokeshi",
year = "2017",
month = "11",
doi = "10.1371/journal.pone.0187962",
language = "English",
volume = "12",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "11",

}

TY - JOUR

T1 - Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers

AU - Maeki, Masatoshi

AU - Fujishima, Yuka

AU - Sato, Yusuke

AU - Yasui, Takao

AU - Kaji, Noritada

AU - Ishida, Akihiko

AU - Tani, Hirofumi

AU - Baba, Yoshinobu

AU - Harashima, Hideyoshi

AU - Tokeshi, Manabu

PY - 2017/11

Y1 - 2017/11

N2 - Lipid nanoparticles (LNPs) or liposomes are the most widely used drug carriers for nanomedicines. The size of LNPs is one of the essential factors affecting drug delivery efficiency and therapeutic efficiency. Here, we demonstrated the effect of lipid concentration and mixing performance on the LNP size using microfluidic devices with the aim of understanding the LNP formation mechanism and controlling the LNP size precisely. We fabricated microfluidic devices with different depths, 11 μm and 31 μm, of their chaotic micromixer structures. According to the LNP formation behavior results, by using a low concentration of the lipid solution and the microfluidic device equipped with the 31 μm chaotic mixer structures, we were able to produce the smallest-sized LNPs yet with a narrow particle size distribution. We also evaluated the mixing rate of the microfluidic devices using a laser scanning confocal microscopy and we estimated the critical ethanol concentration for controlling the LNP size. The critical ethanol concentration range was estimated to be 60–80% ethanol. Ten nanometer-sized tuning of LNPs was achieved for the optimum residence time at the critical concentration using the microfluidic devices with chaotic mixer structures. The residence times at the critical concentration necessary to control the LNP size were 10, 15–25, and 50 ms time-scales for 30, 40, and 50 nm-sized LNPs, respectively. Finally, we proposed the LNP formation mechanism based on the determined LNP formation behavior and the critical ethanol concentration. The precise size-controlled LNPs produced by the microfluidic devices are expected to become carriers for next generation nanomedicines and they will lead to new and effective approaches for cancer treatment.

AB - Lipid nanoparticles (LNPs) or liposomes are the most widely used drug carriers for nanomedicines. The size of LNPs is one of the essential factors affecting drug delivery efficiency and therapeutic efficiency. Here, we demonstrated the effect of lipid concentration and mixing performance on the LNP size using microfluidic devices with the aim of understanding the LNP formation mechanism and controlling the LNP size precisely. We fabricated microfluidic devices with different depths, 11 μm and 31 μm, of their chaotic micromixer structures. According to the LNP formation behavior results, by using a low concentration of the lipid solution and the microfluidic device equipped with the 31 μm chaotic mixer structures, we were able to produce the smallest-sized LNPs yet with a narrow particle size distribution. We also evaluated the mixing rate of the microfluidic devices using a laser scanning confocal microscopy and we estimated the critical ethanol concentration for controlling the LNP size. The critical ethanol concentration range was estimated to be 60–80% ethanol. Ten nanometer-sized tuning of LNPs was achieved for the optimum residence time at the critical concentration using the microfluidic devices with chaotic mixer structures. The residence times at the critical concentration necessary to control the LNP size were 10, 15–25, and 50 ms time-scales for 30, 40, and 50 nm-sized LNPs, respectively. Finally, we proposed the LNP formation mechanism based on the determined LNP formation behavior and the critical ethanol concentration. The precise size-controlled LNPs produced by the microfluidic devices are expected to become carriers for next generation nanomedicines and they will lead to new and effective approaches for cancer treatment.

UR - http://www.scopus.com/inward/record.url?scp=85035790108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035790108&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0187962

DO - 10.1371/journal.pone.0187962

M3 - Article

C2 - 29182626

AN - SCOPUS:85035790108

VL - 12

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 11

M1 - e0187962

ER -